116 related articles for article (PubMed ID: 37983727)
21. Current insights into the oncogenic roles of lncRNA LINC00355.
Shen J; Su X; Pan M; Wang Z; Ke Y; Wang Q; Dong J; Duan S
Cancer Innov; 2023 Dec; 2(6):448-462. PubMed ID: 38125763
[TBL] [Abstract][Full Text] [Related]
22. A novel long non-coding RNA LINC00355 promotes proliferation of lung adenocarcinoma cells by down-regulating miR-195 and up-regulating the expression of CCNE1.
Liang Y; Rong X; Luo Y; Li P; Han Q; Wei L; Wang E
Cell Signal; 2020 Feb; 66():109462. PubMed ID: 31689506
[TBL] [Abstract][Full Text] [Related]
23. HBXIP promotes gastric cancer
Yang Z; Jiang X; Li D; Jiang X
Aging (Albany NY); 2020 Oct; 12(24):24967-24982. PubMed ID: 33048840
[TBL] [Abstract][Full Text] [Related]
24. KIAA1429 regulates cell proliferation by targeting c-Jun messenger RNA directly in gastric cancer.
Miao R; Dai CC; Mei L; Xu J; Sun SW; Xing YL; Wu LS; Wang MH; Wei JF
J Cell Physiol; 2020 Oct; 235(10):7420-7432. PubMed ID: 32052427
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
[TBL] [Abstract][Full Text] [Related]
26. LncRNA GClnc1 Promotes Gastric Carcinogenesis and May Act as a Modular Scaffold of WDR5 and KAT2A Complexes to Specify the Histone Modification Pattern.
Sun TT; He J; Liang Q; Ren LL; Yan TT; Yu TC; Tang JY; Bao YJ; Hu Y; Lin Y; Sun D; Chen YX; Hong J; Chen H; Zou W; Fang JY
Cancer Discov; 2016 Jul; 6(7):784-801. PubMed ID: 27147598
[TBL] [Abstract][Full Text] [Related]
27. SRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesis.
Huang T; Zhou Y; Zhang J; Wong CC; Li W; Kwan JSH; Yang R; Chan AKY; Dong Y; Wu F; Zhang B; Cheung AHK; Wu WKK; Cheng ASL; Yu J; Wong N; Kang W; To KF
Oncogene; 2018 Mar; 37(9):1159-1174. PubMed ID: 29234151
[TBL] [Abstract][Full Text] [Related]
28. The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer.
Xu Y; Song M; Hong Z; Chen W; Zhang Q; Zhou J; Yang C; He Z; Yu J; Peng X; Zhu Q; Li S; Ji K; Liu M; Zuo Q
J Exp Clin Cancer Res; 2023 Jan; 42(1):10. PubMed ID: 36609396
[TBL] [Abstract][Full Text] [Related]
29. lncRNA LINC00355 Acts as a Novel Biomarker and Promotes Glioma Biological Activities via the Regulation of miR-1225/FNDC3B.
Qi ZY; Wang LL; Qu XL
Dis Markers; 2021; 2021():1683129. PubMed ID: 34603558
[TBL] [Abstract][Full Text] [Related]
30. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
[TBL] [Abstract][Full Text] [Related]
31. FTO demethylates m6A modifications in CDKAL1 mRNA and promotes gastric cancer chemoresistance by altering mitochondrial dynamics.
Liu N; Liu C; Wang Z; Wang L; Wang J; Kong J
Clin Exp Pharmacol Physiol; 2023 Apr; 50(4):307-315. PubMed ID: 36628934
[TBL] [Abstract][Full Text] [Related]
32. CircKIAA0907 Retards Cell Growth, Cell Cycle, and Autophagy of Gastric Cancer In Vitro and Inhibits Tumorigenesis In Vivo via the miR-452-5p/KAT6B Axis.
Zhu L; Wang C; Lin S; Zong L
Med Sci Monit; 2020 Jul; 26():e924160. PubMed ID: 32722658
[TBL] [Abstract][Full Text] [Related]
33. lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus.
Liu HT; Zou YX; Zhu WJ; Sen-Liu ; Zhang GH; Ma RR; Guo XY; Gao P
Cell Death Differ; 2022 Mar; 29(3):627-641. PubMed ID: 34608273
[TBL] [Abstract][Full Text] [Related]
34. HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma.
Jia C; Guo Y; Chen Y; Wang X; Xu Q; Zhang Y; Quan L
J Transl Med; 2022 Nov; 20(1):537. PubMed ID: 36401285
[TBL] [Abstract][Full Text] [Related]
35. CTCF-induced upregulation of LINC01207 promotes gastric cancer progression via miR-1301-3p/PODXL axis.
Yu L; Gao Y; Ji B; Feng Z; Li T; Luan W
Dig Liver Dis; 2021 Apr; 53(4):486-495. PubMed ID: 33495099
[TBL] [Abstract][Full Text] [Related]
36. Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m
Liu H; Li D; Sun L; Qin H; Fan A; Meng L; Graves-Deal R; Glass SE; Franklin JL; Liu Q; Wang J; Yeatman TJ; Guo H; Zong H; Jin S; Chen Z; Deng T; Fang Y; Li C; Karijolich J; Patton JG; Wang X; Nie Y; Fan D; Coffey RJ; Zhao X; Lu Y
Mol Cancer; 2022 Mar; 21(1):74. PubMed ID: 35279145
[TBL] [Abstract][Full Text] [Related]
37.
Li J; Wang X; Wang Y; Yang Q
Epigenomics; 2020 Jun; 12(12):989-1002. PubMed ID: 32432496
[No Abstract] [Full Text] [Related]
38. m6A-enriched lncRNA LINC00839 promotes tumor progression by enhancing TAF15-mediated transcription of amine oxidase AOC1 in nasopharyngeal carcinoma.
Zheng WH; Long ZQ; Zheng ZQ; Zhang LL; Liang YL; Li ZX; Lv JW; Kou J; Hong XH; He SW; Xu R; Zhou GQ; Liu N; Ma J; Sun Y; Lin L; Wei D
J Biol Chem; 2023 Jul; 299(7):104873. PubMed ID: 37257820
[TBL] [Abstract][Full Text] [Related]
39. The novel GINS4 axis promotes gastric cancer growth and progression by activating Rac1 and CDC42.
Zhu Z; Yu Z; Rong Z; Luo Z; Zhang J; Qiu Z; Huang C
Theranostics; 2019; 9(26):8294-8311. PubMed ID: 31754397
[No Abstract] [Full Text] [Related]
40. METTL3/YTHDF1 m
Zhi D; Zhou K; Liu S; Yu W; Dong M; Yan C
Pathol Res Pract; 2024 Jan; 253():155047. PubMed ID: 38154356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
